The investment seeks capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerDiscretionary
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| THNR | 26.22 | 0.24 | +0.92% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| FSMD | 44.26 | 0.19 | +0.43% |
| Fidelity Small-Mid Multifactor ETF | |||
| QARP | 58.72 | 0.19 | +0.32% |
| Xtrackers Russell 1000 US QARP ETF | |||
| SPCZ | 28.71 | N/A | N/A |
| RiverNorth Ehd PMgr SPAC ETF | |||
| MCI | 20.99 | -0.02 | -0.10% |
| Barings Corporate Investors | |||
A.I.dvisor indicates that over the last year, FSCPX has been closely correlated with VCDAX. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if FSCPX jumps, then VCDAX could also see price increases.
| Ticker / NAME | Correlation To FSCPX | 1D Price Change % | ||
|---|---|---|---|---|
| FSCPX | 100% | N/A | ||
| VCDAX - FSCPX | 96% Closely correlated | N/A | ||
| FSRPX - FSCPX | 91% Closely correlated | N/A | ||
| RYRIX - FSCPX | 86% Closely correlated | N/A | ||
| RYRAX - FSCPX | 86% Closely correlated | N/A | ||
| RYRTX - FSCPX | 86% Closely correlated | N/A | ||
More | ||||